95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.68%
Revenue growth above 1.5x FSM's 0.16%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
0.02%
Gross profit growth under 50% of FSM's 12.30%. Michael Burry would be concerned about a severe competitive disadvantage.
0.37%
EBIT growth below 50% of FSM's 32.88%. Michael Burry would suspect deeper competitive or cost structure issues.
0.37%
Operating income growth under 50% of FSM's 32.88%. Michael Burry would be concerned about deeper cost or sales issues.
-1.53%
Negative net income growth while FSM stands at 15.40%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Share count expansion well above FSM's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.02%
Diluted share count expanding well above FSM's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
-29.69%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
3.56%
OCF growth under 50% of FSM's 69.89%. Michael Burry might suspect questionable revenue recognition or rising costs.
3.57%
FCF growth under 50% of FSM's 1639.70%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
157.92%
10Y revenue/share CAGR at 50-75% of FSM's 211.73%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
0.79%
5Y revenue/share CAGR under 50% of FSM's 14.04%. Michael Burry would suspect a significant competitive gap or product weakness.
-0.77%
Negative 3Y CAGR while FSM stands at 10.10%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
139.61%
10Y OCF/share CAGR 1.25-1.5x FSM's 113.68%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-19.65%
Negative 5Y OCF/share CAGR while FSM is at 14.47%. Joel Greenblatt would question the firm’s operational model or cost structure.
-13.05%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
74.58%
Below 50% of FSM's 235.72%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-55.47%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
1100.37%
3Y net income/share CAGR above 1.5x FSM's 4.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
235.48%
10Y equity/share CAGR above 1.5x FSM's 145.39%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.34%
5Y equity/share CAGR at 50-75% of FSM's 62.21%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
14.09%
Below 50% of FSM's 57.56%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-17.06%
Negative 5Y dividend/share CAGR while FSM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
65.81%
3Y dividend/share CAGR of 65.81% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
56.16%
AR growth well above FSM's 4.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
-100.00%
Inventory is declining while FSM stands at 12.60%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.01%
Negative asset growth while FSM invests at 2.37%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.66%
Under 50% of FSM's 2.25%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.39%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-4.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.